Paintings of an artist with Alzheimer’s disease: visuoconstructural deficits during dementia K. MaurerD. Prvulovic OriginalPaper Pages: 235 - 245
Core biological marker candidates of Alzheimer’s disease – perspectives for diagnosis, prediction of outcome and reflection of biological activity H. HampelA. MitchellH.-J. Möller OriginalPaper 03 December 2003 Pages: 247 - 272
Immunoreactivities of amyloid β peptide(1–42) and total τ protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus H. LinsI. WichartN. Rösler OriginalPaper 03 December 2003 Pages: 273 - 280
Neuroinflammatory perspectives on the two faces of Alzheimer’s disease P. EikelenboomW. A. van Gool OriginalPaper 03 December 2003 Pages: 281 - 294
(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia L. FrölichM. E. GötzP. Riederer OriginalPaper 24 October 2003 Pages: 295 - 310
Impairment of Gsα function in human brain cortex of Alzheimer’s disease: comparison with normal aging E. HashimotoH. OzawaL. Frölich OriginalPaper 29 December 2003 Pages: 311 - 322
Alzheimer’s disease and NGF signaling A. SalehiJ.-D. DelcroixD. F. Swaab OriginalPaper Pages: 323 - 345
Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity M. WeinstockS. Shoham OriginalPaper 12 December 2003 Pages: 347 - 366
Gene expression profile in streptozotocin rat model for sporadic Alzheimer’s disease E. GrünblattS. HoyerP. Riederer OriginalPaper 13 August 2003 Pages: 367 - 386
State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations U. E. LangM. C. Jockers-ScherüblR. Hellweg OriginalPaper 29 December 2003 Pages: 387 - 411
Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology M. H. MohajeriK. D. SainiR. M. Nitsch OriginalPaper 03 December 2003 Pages: 413 - 425
Differential effects of “Advanced glycation endproducts” and β-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y B. KuhlaC. LoskeG. Münch OriginalPaper 15 September 2003 Pages: 427 - 439
Pentoxyphylline and propentophylline are inhibitors of TNF-α release in monocytes activated by advanced glycation endproducts I. MeinersS. HauschildtG. Münch Short Communication 03 December 2003 Pages: 441 - 447